Abstract
Cigarette smoking alters the immune system and may improve cognitive deficits in neuropsychiatric disorders. Smoking prevalence is high in human immunodeficiency virus (HIV)—infected patients; however, its effect on HIV-associated cognitive impairment remains unknown in the era of antiretroviral treatment. The authors examined associations of smoking with viral immune profile and cognitive function in a cohort of HIV-seropositive women. This observational cross-sectional study included 56 women (36 HIV-seropositive and 20 HIV-seronegative) surveyed with a tobacco questionnaire: the Fagerström Test for Nicotine Dependency. Viral immune status was obtained 6 to 12 months before questioned. Neurocognitive testing (NP) assessed verbal memory, frontal/executive function, psychomotor speed, and motor speed. A reference group of HIV-seronegative women was used to calculate standardized z-scores. Cognitive impairment was classified using a modified American Academy of Neurology criteria, adding an asymptomatic group based on NP tests. Statistics included parametric and nonparametric tests. HIV-seropositive women were more likely to report a history of smoking (P = 0.028). Among them, current smoking correlated with higher plasma viral load (P = 0.048), and history of smoking correlated with lower CD4 cell count (P = 0.027). The authors observed no associations between cognitive impairment and either current or past history of smoking and no differences in neurocognitive domain scores between HIV-seropositive and -seronegative women or between those with and without a history of smoking. However, restricting analysis to HIV-seropositives showed a significant better performance on the frontal/executive domain in those with history of smoking. In summary, history of smoking correlated with better frontal/executive cognitive domain performance in HIV-seropositive women and with worse viral immune profile.
Similar content being viewed by others
References
American Academy of Neurology AIDS Task Force (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41: 778–785.
American Academy of Neurology AIDS Task Force (1996). Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. Neurology 47: 1247–1253.
Becona E, Vazquez FL (1998). The Fagerstrom Test for Nicotine Dependence in a Spanish sample. Psychol Rep, 83: 1455–1458.
Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P 3rd (2006). Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 79: 480–488.
Burns DN, Kramer A, Yellin F, Fuchs D, Wachter H, DiGioia RA, Sanchez WC, Grossman RJ, Gordin FM, Biggar RJ, Goedert JJ (1991). Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection? J Acquir Immune Defic Syndr 4: 76–83.
CDC (2006). HIV/AIDS among Youth. http://www.cdc. gov/hiv/resourses/factsheets/youth.htm.
Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD (1996). The association between cigarette smoking and selected HIV-related medical conditions. AIDS 10: 1121–1126.
Crothers K, Griffith TA, McGinnis KA, Rodriguez-Barradas MC, Leaf DA, Weissman S, Gibert CL, Butt AA, Justice AC (2005). The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 20: 1142–1145.
Dani JA, Bertrand D (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47: 699–729.
Davis TM, Rodriguez VL (1979). Comparison of scores on the WAIS and its Puerto Rican counterpart, Escala de Inteligencia Wechsler para Adultos, in an institutionalized Latin American psychiatric population. J Consult Clin Psychol 47: 181–182.
de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM (1995). Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry 152: 453–455.
De Simone R, Ajmone-Cat MA, Carnevale D, Minghetti L (2005). Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J Neuroinflamm 2: 4.
Demsky YI, Gass CS, Golden CJ (1998). Interpretation of VIQ-PIQ and intersubtest differences on the Spanish version of the WAIS. Assessment 5: 25–30.
Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, Gandhi M, Mocharnuk RS, Anastos K (2006). Association of cigarette smoking with hiv prognosis among women in the HAART era: a report from the Women’s Interagency HIV Study. Am J Public Health 96: 1060–1065.
Furber AS, Maheswaran R, Newell JN, Carroll C (2007). Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systemic review. Sex Transm Infect 83: 41–46.
Galanis DJ, Petrovitch H, Launer LJ, Harris TB, Foley DJ, White LR (1997). Smoking history in middle age and subsequent cognitive performance in elderly Japanese-American men. The Honolulu-Asia Aging Study. Am J Epidemiol 145: 507–515.
Giunta B, Ehrhart J, Townsend K, Sun N, Vendrame M, Shytle D, Tan J, Fernandez F (2004). Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120. Brain Res Bull 64: 165–170.
Gonzalez-Lira B, Rueda-Orozco PE, Galicia O, Montes-Rodriguez CJ, Guzman K, Guevara-Martinez M, Elder JH, Prospero-Garcia O (2006). Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats. Neurosci Lett 394: 136–139.
Gritz ER, Vidrine DJ, Lazev AB, Amick BC 3rd, Arduino RC (2004). Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res 6: 71–77.
Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, Guyatt GH, Norton PG, Dunn E (1996). A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 24: 161–175.
Hill RD, Nilsson LG, Nyberg L, Backman L (2003). Cigarette smoking and cognitive performance in healthy Swedish adults. Age Ageing 32: 548–550.
Holt PG (1987). Immune and inflammatory function in cigarette smokers. Thorax 42: 241–249.
Hosli E, Ruhl W, Hosli L (2000). Histochemical and electrophysiological evidence for estrogen receptors on cultured astrocytes: colocalization with cholinergic receptors. Int J Dev Neurosci 18: 101–111.
Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA (1986). Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143: 993–997.
Mamary EM, Bahrs D, Martinez S (2002). Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS 16: 39–42.
Masterson E, O’Shea B (1984). Smoking and malignancy in schizophrenia. Br J Psychiatry 145: 429–432.
MMWR (2006). Use of cessation methods among smokers aged 16–24 years—United States, 2003. MMWR Mort Morb Wkly Rep 55: 1351–1354.
Mueck AO, Seeger H (2005). Smoking, estradiol metabolism and hormone replacement therapy. Curr Med Chem Cardiovasc Hematol Agents 3: 45–54.
Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB (2000). Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis 31: 808–812.
O’Farrell TJ, Connors GJ, Upper D (1983). Addictive behaviors among hospitalized psychiatric patients. Addict Behav 8: 329–333.
Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kem WR, Freedman R (2006). Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 63: 630–638.
Ott A, Andersen K, Dewey ME, Letenneur L, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A, Launer LJ (2004). Effect of smoking on global cognitive function in nondemented elderly. Neurology 62: 920–924.
Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W, Jr. (1996). Comorbidity and survival in HIV-infected men in the San Francisco Men’s Health Survey. Ann Epidemiol 6: 420–430.
Perkins KA (2001). Smoking cessation in women. Special considerations. CNS Drugs 15: 391–411.
Perkins KA, Doyle T, Ciccocioppo M, Conklin C, Sayette M, Caggiula A (2006). Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking. Psychopharmacology (Berl) 184: 600–607.
Poundstone KE, Chaisson RE, Moore RD (2001). Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS 15: 1115–1123.
Razani J, Boone K, Lesser I, Weiss D (2004). Effects of cigarette smoking history on cognitive functioning in healthy older adults. Am J Geriatr Psychiatry 12: 404–411.
Richards M, Jarvis MJ, Thompson N, Wadsworth ME (2003). Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort study. Am J Public Health 93: 994–998.
Royce RA, Winkelstein W Jr (1990). HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men’s Health Study. AIDS 4: 327–333.
Sacco KA, Bannon KL, George TP (2004). Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol 18: 457–474.
Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP (2005). Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62: 649–659.
Shytle RD, Mori T, Townsend K, Vendrame M, Sun N, Zeng J, Ehrhart J, Silver AA, Sanberg PR, Tan J (2004). Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem 89: 337–343.
Sopori M (2002). Effects of cigarette smoke on the immune system. Nat Rev Immunol 2: 372–377.
Svensson AL, Nordberg A (1999). Beta-estradiol attenuate amyloid beta-peptide toxicity via nicotinic receptors. Neuroreport 10: 3485–3489.
Tollerud DJ, Brown LM, Blattner WA, Mann DL, Pankiw-Trost L, Hoover RN (1991). T cell subsets in healthy black smokers and nonsmokers. Evidence for ethnic group as an important response modifier. Am Rev Respir Dis 144: 612–616.
Tollerud DJ, Clark JW, Brown LM, Neuland CY, Mann DL, Pankiw-Trost LK, Blattner WA, Hoover RN (1989). The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. Am Rev Respir Dis 139: 1446–1451.
Tracey KJ (2002). The inflammatory reflex. Nature 420: 853–859.
Turner J, Page-Shafer K, Chin DP, Osmond D, Mossar M, Markstein L, Huitsing J, Barnes S, Clemente V, Chesney M (2001). Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDS 15: 615–624.
Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ (2003). Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384–388.
Williams, J (2002). Women and smoking: sensory factors, attitudes about weight, phase of menstrual cycle all key to quitting. NIDA notes.
Wojna V, Nath A (2006). Challenges to the diagnosis and management of HIV dementia. AIDS Read 16: 615–616, 621–624, 626, 629–632.
Wojna V, Skolasky R, Hechavarria R, Mayo R, Selnes O, McArthur JC, Melendez L, Maldonado E, Zorrilla C, Garcia H, Kraiselburd E, Nath A (2006). Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J NeuroVirol 12: 1–9.
Ziedonis DM, Kosten TR, Glazer WM, Frances RJ (1994). Nicotine dependence and schizophrenia. Hosp Community Psychiatry 45: 204–206.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by S11NS046278, U54NS43011, and P20RR11126. P20RR11126 is a grant from the National Center for Research Resources (NCRR) a component of the National Institutes of Health (NIH).
Rights and permissions
About this article
Cite this article
Wojna, V., Robles, L., Skolasky, R.L. et al. Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women. Journal of NeuroVirology 13, 561–568 (2007). https://doi.org/10.1080/13550280701620747
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280701620747